Haiti vs Syrian Arab Republic: Previously treated cases tested for RR-/MDR-TB
Haiti
35.0%
in 2024
Syrian Arab Republic
32.0%
in 2024
Haiti rank
157th
Syrian Arab Republic rank
160th
Previously treated cases tested for RR-/MDR-TB over time
- Haiti
- Syrian Arab Republic
How they compare
Haiti currently reports 35.0% against 32.0% in Syrian Arab Republic, a difference of 3.0%.
That makes Haiti's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 5 times across 15 shared years of data; in 2007 it was Syrian Arab Republic ahead.
Haiti ranks 157th and Syrian Arab Republic ranks 160th of 180 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Haiti | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.0% | 7.5% | 1.5% | Syrian Arab Republic |
| 2010s | 16.7% | 42.7% | 26.0% | Syrian Arab Republic |
| 2020s | 35.3% | 86.4% | 51.1% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Haiti or Syrian Arab Republic?
- Haiti, at 35.0% against 32.0% in Syrian Arab Republic as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Haiti and Syrian Arab Republic?
- 3.0%, with Haiti ahead.
- How many years of comparable data are there for Haiti and Syrian Arab Republic?
- 15 years are reported by both, from 2007 to 2024.
- How do Haiti and Syrian Arab Republic rank globally for previously treated cases tested for rr-/mdr-tb?
- Haiti ranks 157th and Syrian Arab Republic ranks 160th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.